Heterogeneity of Kras status in primary colorectal cancer and corresponding liver metastases.

被引：0
|
作者：
Kaneko, Y. [1 ]
Kuramochi, H. [1 ]
Nakajima, G. [1 ]
Nakamura, A. [1 ]
Inoue, Y. [1 ]
Hayashi, K. [1 ]
Yamamoto, M. [1 ]
机构：
[1] Tokyo Womens Med Univ, Tokyo, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.e14037
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14037
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Intratumoral heterogeneity of KRAS and BRAF mutations in primary colorectal cancer and corresponding metastases
    Zlobec, I.
    Bihl, M.
    Foerster, A.
    Rufle, A.
    Lugli, A.
    VIRCHOWS ARCHIV, 2011, 459 : S318 - S318
  • [2] EVALUATION OF KRAS MUTATION STATUS IN PRIMARY COLORECTAL TUMOURS AND CORRESPONDING LIVER METASTASES
    Knijn, N.
    Mekenkamp, L. J. M.
    Klomp, M.
    Vink-Borger, E.
    Tol, J.
    Teerenstra, S.
    Meijer, J.
    Tebar, M.
    Punt, C. J. A.
    Nagtegaal, I. D.
    ANNALS OF ONCOLOGY, 2010, 21 : 193 - 193
  • [3] Amphiregulin and epiregulin mRNA expression in primary colorectal cancer and corresponding liver metastases.
    Kuramochi, H.
    Nakajima, G.
    Kaneko, Y.
    Nakamura, A.
    Inoue, Y.
    Okuyama, R.
    Kondo, Y.
    Kanemura, T.
    Hayashi, K.
    Yamamoto, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [4] Degraded DNA may induce discordance of KRAS status between primary colorectal cancer and corresponding liver metastases
    Kaneko, Yuka
    Kuramochi, Hidekazu
    Nakajima, Go
    Inoue, Yuji
    Yamamoto, Masakazu
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2014, 19 (01) : 113 - 120
  • [5] Degraded DNA may induce discordance of KRAS status between primary colorectal cancer and corresponding liver metastases
    Yuka Kaneko
    Hidekazu Kuramochi
    Go Nakajima
    Yuji Inoue
    Masakazu Yamamoto
    International Journal of Clinical Oncology, 2014, 19 : 113 - 120
  • [6] Tumor Heterogeneity in Primary Colorectal Cancer and Corresponding Metastases. Does the Apple Fall Far From the Tree?
    Blank, Annika
    Roberts, Daniel Edward Il
    Dawson, Heather
    Zlobec, Inti
    Lugli, Alessandro
    FRONTIERS IN MEDICINE, 2018, 5
  • [7] 5-fluorouracil related gene expression levels in primary colorectal cancer and corresponding liver metastases.
    Kuramochi, H
    Hayashi, K
    Uchida, K
    Shimizu, D
    Vallboehmer, D
    Park, SJ
    Miyakura, S
    Danenberg, KD
    Takasaki, K
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 263S - 263S
  • [8] Relevance of CEA and LDH in relation to KRAS status in patients with unresectable colorectal liver metastases.
    Connell, Louise Catherine
    Chou, Joanne F.
    Boucher, Taryn Mary
    Capanu, Marinela
    Kemeny, Nancy E.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [9] KRAS mutation status in primary colorectal cancer and in matched metastases
    Dietmaier, W.
    Kiesl, A.
    Vogel, C.
    Groesch, B.
    Ruemmele, P.
    Hofstaedter, F.
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2009, 24 : S39 - S39
  • [10] THE PROGNOSTIC IMPACT OF PRIMARY TUMOR SITE AND KRAS MUTATION AFTER CURATIVE INTENT SURGERY FOR COLORECTAL CANCER WITH LIVER METASTASES.
    Kim, H.
    Yang, S.
    Han, Y.
    Cho, M.
    Hur, H.
    Min, B.
    Lee, K.
    Kim, N.
    DISEASES OF THE COLON & RECTUM, 2020, 63 (06) : E276 - E277
12345